Molecular Networks

Curated by Signal

Cheminformatics software for drug discovery

Overview

MN-AM is a developer of chemoinformatics software for drug discovery. The ChemTunes ToxGPS chemoinformatics software is used for platform and database offers in vitro and in vivo toxicity data for safety evaluation and risk assessment of chemical compounds.

Key facts

Founded: 1997
Headquarters: Nuremberg, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Dytrex
Develops and markets hometesting diagnostic products
Life Sciences TechnologyBerlin, Germany
RooWalk
Provider of electric mobility aid for motion-impaired children and adults
Life Sciences TechnologyBerlin, Germany
Steptics
Provider of composite prosthesis for amputees
Life Sciences TechnologyMunchen, Germany

About Molecular Networks

What does Molecular Networks do?

MN-AM is a developer of chemoinformatics software for drug discovery.

Where is Molecular Networks headquartered?

Molecular Networks is headquartered in Nuremberg, Germany.

When was Molecular Networks founded?

Molecular Networks was founded in 1997.

Which sector is Molecular Networks in?

Molecular Networks operates in Life Sciences Technology.

Who are Molecular Networks's competitors?

Companies similar to Molecular Networks include Dytrex, RooWalk, and Steptics.